Overexpression of STC2, ENO3, P4HA1, and CHPF2 and low expression of PPP2CB, PPARGC1A, PMM2, and PGM2 are associated with lower OS rate in COAD patients (Supplementary Figure 4). This evidence concerns the gene PGM2 and colon adenocarcinoma.